R. Cosentini (Milan, Italy), S. Ewig (Bochum, Germany)
The role of serum inflammatory markers in the detection of ventilation associated pneumonia (VAP)
M. Efstratios, M. Demosthenes, S. Nikos, Z. Paris, A. Olympia, G. Anastasios, S. Mattheos, Z. Epaminontas (Larisa, Greece)
|   |
Diagnostic and prognostic utility of procalcitonin (PCT) measurements in patients with hospitalized community-acquired pneumonia (CAP)
M. Horie, M. Ugajin, M. Suzuki, M. Ohata, S. Noguchi, H. Tamiya, H. Yoshihara, Y. Kichikawa, Y. Sakamoto (Setagayaku Kamiyouga, Hamamatsu, Japan)
| |
Biomarkers and clinical stability in community-acquired pneumonia
R. Menéndez, S. Reyes, R. Martínez, C. Esquinas, R. Piñer, A. Martínez, J. Mensa, X. Filella, A. Torres (Valencia, Barcelona, Spain)
| |
Influence of older age on biomarker concentrations in patients with community acquired pneumonia
S. Krueger, J. Kunde, R. Marre, N. Suttorp, T. Welte (Aachen, Henningsdorf, Ulm, Berlin, Hannover, Germany)
| |
Procalcitonin and neopterin in community-acquired pneumonia – correlation with microbial aetiology, severity and mortality
S. Krueger, J. Kunde, R. Marre, N. Suttorp, T. Welte (Aachen, Hennigsdorf, Ulm, Berlin, Hannover, Germany)
| |
Measurements usefulness of serum C-reactive protein for management of adult community-acquired pneumonia
H. Shoji, K. Yoshida, Y. Niki (Tokyo, Japan)
| |
A simplified physiological scoring system for predicting severity in community acquired pneumonia – an international derivation and validation study
J. D. Chalmers, K. L. Buising, P. Peyrani, A. Singanayagam, J. Ramirez, A. T. Hill (Edinburgh, United Kingdom; Melbourne, Australia; Louisville, United States Of America)
| |
Community-acquired pneumonia: aetiology and severity scores
C. Cilloniz, E. Polverino, C. Esquinas, J. A. Riesco, J. Mensa, M. A. Marcos, M. Ortega, R. Menendez, A. Torres (Barcelona, Valencia, Spain)
| |
Risk factors for hospitalisation of CAP patients initially treated in an outpatient setting
P. Heyer, H. Kothe, B. Maike, S. Maike, T. Bauer, N. Suttorp, T. Welte, K. Dalhoff (Luebeck, Berlin, Hannover, Germany)
| |
Performance of CURB-65 and CURB-age in community acquired pneumonia (CAP)
P. Sankaran, P. Myint, P. Musonda, D. Subramanian, H. Ruffell, A. Smith, P. Prentice, S. Tariq, A. Kamath (Norwich, KingsLynn, United Kingdom)
| |
Severity assessment tools for predicting 30-day mortality in community acquired pneumonia – systematic review and meta-analysis
J. D. Chalmers, A. Singanayagam, A. T. Hill (Edinburgh, United Kingdom)
| |
Ability of the reduced severity rule crb-65 to detect high risk of short-term mortality from pneumonia in elderly patients
A. Vila-Corcoles, I. Hospital-Guardiola, M. Juarez-laiz, C. De Diego-Cabanes, D. Rovira-veciana, EPIVAC Study Group (Tarragona, Spain)
| |
Apache II score and prediction of ventilator-associated pneumonia (VAP)
P. Peyrani, T. Wiemken, P. Cabral, M. Gnoni, M. Luz Paz, M. Del Carmen Venero, J. Ramirez (Louisville, United States Of America)
| |
Comparison of the two scoring indices (curb65 and psi) and detemination of their utility in predicting the severity of community acquired pneumonia among patients seen at philippine heart center
M. Banate, A. Banzon, F. Ayuyao, T. De Guia (Quezon City, Philippines)
| |
A new severity score for community-acquired pneumonia: PARB score
N. Uchiyama, S. Gotoh, R. Suda, S. Yamao, H. Horinouchi, R. Sugiura, Y. Tomishima, T. Jinta, N. Nishimura, N. Chohnabayashi (Tokyo, Japan)
| |
A comparative estimate of clinical indices in patients with community acquired lower respiratory tract infections (LRTIs), admitted in the intensive care unit (ICU) and pulmonary ward
P. Nikolova, Y. Ivanov, P. Hristova, P. Pavlov, T. Popova (Pleven, Bulgaria)
| |
Scoring systems for estimation of severity community acquired pneumonia – our impressions
M. Roksandic, M. Mitic-Milikic, N. Samardzic, V. Milenkovic (Belgrade, Republic Of Serbia)
| |
Outcomes of patients admitted with community acquired pneumonia following the introduction of new hospital guidelines in a district general hospital
A. Janjua, N. Sinnott, U. Saeed, M. Holland, M. Babores (Macclesfield, United Kingdom)
| |
Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients
M. Gosset-Woimant, C. Andrejak, C. Poulet, D. Basille, H. Bentayeb, M. Boutemy, E. Lecuyer, S. Thielen, N. Benoit, J. Montconduit, F. Martin, O. Leleu, C. Clarot, V. Jounieaux, C. Dayen, Y. Douadi (Amiens, Saint Quentin, Compiègne, Abbeville, France)
| |